The maintenance of CD4+ T-cells and CD8+ T-cells numbers characterizes the efficacy of HAART [22–24], which inhibits viral replication, slows the progression of immunodeficiency, and therefore restores immunity, increasing the quality of life of HIV-1-infected individuals. This evidence concerns the gene CD8A and immune system disorder.